Related Experiment Videos
Magnetic resonance molecular imaging with nanoparticles
Gregory M Lanza1, Patrick M Winter, Shelton D Caruthers
1Division of Cardiology, Washington University Medical School, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
Summary
Molecular imaging agents enable advanced, noninvasive diagnosis by recognizing cell surface signatures. Magnetic resonance (MR) imaging agents combine diagnostics with targeted drug delivery for rational therapy.
Area of Science:
- Biomedical imaging
- Nanotechnology
- Pharmacology
Background:
- Molecular imaging advances noninvasive medical diagnosis beyond anatomy.
- It now integrates with major clinical imaging modalities, especially magnetic resonance (MR) imaging.
- Cell surface biochemical signatures are key targets for advanced diagnostics.
Purpose of the Study:
- To explore the potential of MR nanoparticulate agents for targeted diagnostics.
- To investigate the integration of MR molecular imaging with drug delivery systems.
- To highlight the development of rational targeted therapies.
Main Methods:
- Utilizing nanoparticulate agents for magnetic resonance (MR) imaging.
- Developing targeted diagnostic capabilities.
- Implementing image-monitored, site-specific therapeutic delivery.
Main Results:
- MR nanoparticulate agents offer dual diagnostic and therapeutic capabilities.
- High-resolution MR molecular imaging allows for treatment verification and quantification.
- This approach facilitates rational targeted therapy.
Conclusions:
- Combining MR molecular imaging with drug delivery represents a "magic bullet" approach.
- This integration promises new clinical strategies for various diseases.
- It enables precise, image-guided, site-specific treatment.